A study for the new regimen of pilocarpine hydrochloride in patients with xerostomia

A study for the new regimen of pilocarpine hydrochloride in patients with xerostomia - A study of pilocarpine hydrochloride in patients with xerostomia

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000018144

Enrollment

Registered

2015-07-01

Start date

2015-07-13

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

xerostomia

Interventions

After pilocaripine hydrochloride (5mg, increscent) is orally administered three times daily for 8 weeks, the granules of pilocaripine hydrochloride (0.5%) as mouthwash is administered three times dail

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Patients with xerostomia 2)Patients with obtained the informed consent in writing

Exclusion criteria

Exclusion criteria: patients who have contraindication to pilocarpine hydrochloride.

Design outcomes

Primary

Measure	Time frame
1)dry mouth questionnaire with the visual analog scale (VAS) 2)total amount of saliva production	—

Countries

Japan

Contacts

Public ContactYoko Kawase-Koga

Tokyo Medical University Department of Oral and Maxillofacial Surgery

kogay@tokyo-med.ac.jp81-3-3342-6111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026